108 related articles for article (PubMed ID: 802473)
1. The dominant role of Ia antibodies in the passive enhancement of H-2 incompatible skin grafts.
Staines NA; Guy K; Davies DA
Eur J Immunol; 1975 Nov; 5(11):782-9. PubMed ID: 802473
[TBL] [Abstract][Full Text] [Related]
2. Ia versus K/D antigens in immunological enhancement of tumour allografts. II. Studies with alloimmune sera prepared in recombinant strains.
Duc HT; Kinsky RG; Voisin GA
Ann Immunol (Paris); 1979; 130C(3):461-74. PubMed ID: 475347
[TBL] [Abstract][Full Text] [Related]
3. Active enhancement of donor-strain skin in mice bearing H-2D-incompatible heart allografts.
Corry RJ; Kelley SE
Transplant Proc; 1977 Mar; 9(1):945-9. PubMed ID: 325825
[No Abstract] [Full Text] [Related]
4. The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
de Waal RM; Capel PJ; Koene RA
J Immunol; 1980 Feb; 124(2):719-23. PubMed ID: 6985936
[TBL] [Abstract][Full Text] [Related]
5. A method for detection of Ia antigens in the absence of appropriate H-2 recombinants.
Hauptfeld M; Hauptfeld V; Klein J
J Immunol; 1975 Aug; 115(2):351-5. PubMed ID: 1080169
[TBL] [Abstract][Full Text] [Related]
6. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. I. Genetics and specificity of anti-Ia immunotherapy in murine skin allograft recipients.
Perry LL; Williams IR
J Immunol; 1985 May; 134(5):2935-41. PubMed ID: 2580008
[TBL] [Abstract][Full Text] [Related]
7. Passive enhancement of mouse skin allografts. Specificity of the antiserum for major histocompatibility.
Staines NA; Guy K; Davies DA
Transplantation; 1974 Aug; 18(2):192-5. PubMed ID: 4602953
[No Abstract] [Full Text] [Related]
8. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
Tomita Y; Mayumi H; Eto M; Nomoto K
J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
[TBL] [Abstract][Full Text] [Related]
9. Prolongation of murine skin allograft survival by immunologic manipulation with anti-interleukin 2 receptor antibody.
Granstein RD; Goulston C; Gaulton GN
J Immunol; 1986 Feb; 136(3):898-902. PubMed ID: 3079802
[TBL] [Abstract][Full Text] [Related]
10. Hyperacute rejection and enhancement of mouse skin grafts by antibodies with a distinct specificity.
Jansen JL; Koene RA; Kamp GJ; Hagemann JF; Wijdeveld PG
J Immunol; 1975 Aug; 115(2):392-4. PubMed ID: 1097512
[TBL] [Abstract][Full Text] [Related]
11. Ia antigens in inbred rats and their relationship to the MLR phenotype.
Radka SF; Cramer DV; Gill TJ
J Immunol; 1977 Dec; 119(6):2037-44. PubMed ID: 144165
[TBL] [Abstract][Full Text] [Related]
12. Ia versus K/D antigens in immunological enhancement of tumor allografts.
Duc HT; Kinsky RG; Voisin GA
Transplantation; 1978 Apr; 25(4):182-7. PubMed ID: 635985
[TBL] [Abstract][Full Text] [Related]
13. In vivo activity of an H-2 alloantiserum purified by affinity chromatography on transplantation antigens.
de Waal RM; Lems SP; Koene RA
Transplantation; 1979 Jun; 27(6):376-9. PubMed ID: 380077
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive ALS. II. Antibody to Ia antigens in heterologous anti-lymphocyte serum.
Zimmerman B; Tsui F; Delovitch T
Immunology; 1979 May; 37(1):179-86. PubMed ID: 381173
[TBL] [Abstract][Full Text] [Related]
15. [Antigenic sites implicated in tumour allograft enhancement].
Duc HT; Kinsky RG; Voisin GA
Ann Immunol (Paris); 1977; 128(1-2):19-20. PubMed ID: 322579
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of passive enhancement].
Soulillou JP; d'Apice AF
Biomedicine; 1977 Apr; 26(2):79-85. PubMed ID: 301409
[TBL] [Abstract][Full Text] [Related]
17. Idiotypic relationship of anti-Ia.2 antibodies.
Grützmann R; Hämmerling GJ
Eur J Immunol; 1982 Apr; 12(4):307-12. PubMed ID: 6954071
[TBL] [Abstract][Full Text] [Related]
18. Reduced diversity of CTLs specific for multiple minor histocompatibility antigens relative to allograft rejection in vivo.
Nevala WK; Paul C; Wettstein PJ
J Immunol; 1997 Feb; 158(3):1102-7. PubMed ID: 9013948
[TBL] [Abstract][Full Text] [Related]
19. Role of Ia-like products of the main histocompatibility complex in conditioning skin allograft survival in man.
Dausset J; Contu L; Legrand L; Marcelli-Barge A; Meo T; Rapaport FT
J Clin Invest; 1979 May; 63(5):893-901. PubMed ID: 376550
[TBL] [Abstract][Full Text] [Related]
20. Anti-L3T4 monoclonal antibodies prolong survival of Ia-antigen disparate skin allografts.
Holán V
Folia Biol (Praha); 1988; 34(2):65-71. PubMed ID: 3294049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
